Similar articles

• Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis.

  Chien JY, Jerng JS, Yu CJ, Yang PC. Chien JY, et al. Crit Care Med. 2005 Aug;33(8):1688-93. doi: 10.1097/01.ccm.0000171183.79525.6b. Crit Care Med. 2005. PMID: 16096442
• HDL in innate and adaptive immunity.

  Catapano AL, Pirillo A, Bonacina F, Norata GD. Catapano AL, et al. Cardiovasc Res. 2014 Aug 1;103(3):372-83. doi: 10.1093/cvr/cvu150. Epub 2014 Jun 15. Cardiovasc Res. 2014. PMID: 24935428 Review.
• [Progress of anti-infection of high density lipoprotein].

  Guo Q, Zou G. Guo Q, et al. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2013 Sep;38(9):954-8. doi: 10.3969/j.issn.1672-7347.2013.09.015. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2013. PMID: 24071695 Chinese.
• The lipemia of sepsis: triglyceride-rich lipoproteins as agents of innate immunity.

  Harris HW, Gosnell JE, Kumwenda ZL. Harris HW, et al. J Endotoxin Res. 2000;6(6):421-30. J Endotoxin Res. 2000. PMID: 11521066 Review.
• Impact of sepsis-induced changes in plasma on LPS interactions with monocytes and plasma lipoproteins: roles of soluble CD14, LBP, and acute phase lipoproteins.

  Kitchens RL, Thompson PA. Kitchens RL, et al. J Endotoxin Res. 2003;9(2):113-8. doi: 10.1179/096805103125001504. J Endotoxin Res. 2003. PMID: 12803885